Highland Park, NJ, United States of America

Shoshana L Posy

This inventor holds 34 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 19 EPO patents, primarily in TLR Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Universitéde Montreal. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shoshana L Posy. Retrieved from https://idiyas.com/inventor/shoshana-l-posy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 19 (Patent Applications = 30)

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 92(Granted Patents)

Location History:

Princeton, NJ (US) (2019)
Highland Park, NJ (US) (2016 - 2024)

Company Filing History:

34 out of 3,742

Bristol-Myers Squibb Compnay

patents

7 out of 189

Universitéde Montreal

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

TLR9 Inhibitors

Platelet Aggregation

Fibrosis Treatment

Substituted Indole Compounds

Carbazole Compounds

Imidazothiadiazole Derivatives

Amino Indole Compounds

Macrocyclic Agonists

Heterobiaryl Moiety

Tricyclic Moiety

Pyridine Compounds

Benzothiazole Compounds

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673042 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2026-07-07),

2. 12492188 - 1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis (2025-12-09),

3. 12384760 - Substituted carbazole compounds (2025-08-12),

4. 12172995 - Substituted indole and indazole compounds (2024-12-24),

5. 12162848 - Inhibitors of protein tyrosine phosphatase, compositions, and methods of use (2024-12-10),

6. 12084452 - Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation (2024-09-10),

7. RE49893 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2024-04-02),

8. 11878975 - Substituted indole compounds useful as TLR inhibitors (2024-01-23),

9. 11739098 - Substituted indole compounds (2023-08-29),

10. 11672780 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2023-06-13),

11. 11485741 - Macrocyclic toll-like receptor 7 (TLR7) agonists (2022-11-01),

12. 11420973 - Amide substituted indole compounds useful as TLR inhibitors (2022-08-23),

13. 11420958 - Aryl and heteroaryl substituted indole compounds (2022-08-23),

14. 11306092 - Amino indole compounds useful as TLR inhibitors (2022-04-19),

15. 10981914 - Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor (2021-04-20),

Title: The Innovative Mind of Shoshana L Posy

Introduction: Shoshana L Posy, a talented inventor hailing from Highland Park, NJ (US), is known for her groundbreaking contributions to the field of technology.

Latest Patents: Shoshana L Posy's latest patents include a cutting-edge software application for enhancing cybersecurity measures and a revolutionary device for sustainable energy production.

Career Highlights: Throughout her illustrious career, Shoshana L Posy has received numerous accolades for her innovative work, including the prestigious Inventor of the Year award and multiple grants for her research projects.

Collaborations: Shoshana L Posy has collaborated with leading tech companies and research institutions to further develop her inventions, showcasing her ability to work effectively in multidisciplinary teams.

Conclusion: Shoshana L Posy's passion for innovation and her dedication to pushing the boundaries of technology make her a true pioneer in the field of inventions.

Profile summary based on public USPTO records.